课题基金 / 基金详情

TGF-beta signaling in the kidney

TGF-beta signaling in the kidney
肾脏中的 TGF-β 信号传导
批准号:
8820727
负责人:
MARY E CHOI
金额:
$19.57万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-01 至 2015-05-31
关键词:

项目摘要

项目成果

MARY E CHOI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):转化生长因子- β 1 (TGF-ss1)是一种多效细胞因子,控制多种细胞功能,包括细胞增殖、分化、凋亡和细胞外基质(ECM)合成。TGF-ss1是ECM蛋白合成和积累的有效诱导剂,作为包括肾脏在内的多种组织中纤维发生的中心介质,在进行性疾病的发病机制中起关键作用。TGF-ss1的作用通过TGF-ss I型(TssRI)和II型(TssRII)受体介导,激活细胞内通路。许多核心问题仍然与不同的受体如何以细胞特异性和环境特异性的方式介导TGF-ss1信号以引发多种细胞反应有关。我们研究的总体目标是了解肾损伤和纤维化的细胞和分子机制。主要目的是研究TGF-ss1信号通路的机制及其在肾脏损伤反应中的调节和功能作用。我们的假设是,自噬是一种适应性应激反应,通过抑制细胞凋亡和促进肾细胞存活来保护肾脏免受损伤,TGF-ss1通过调节自噬发挥细胞保护作用。此外,我们假设TGF-ss1通过TAK1- MKK3-p38信号传导是组织损伤反应的关键介质,其中TGF-ss1调节自噬蛋白,从而阻止细胞凋亡和过度的ECM积累。本课题将重点研究TGF-ss1信号通过TAK1在肾细胞中的作用机制和功能,以及在肾纤维化实验模型中自噬的调控及其生理功能作用。特异性目的1:确定TGF-ss1信号通路TAK1在肾细胞中的作用机制和功能作用。特异性目的2:确定TGF-ss1诱导肾细胞自噬的调控和功能。特异性目的3:确定自噬在肾纤维化实验模型中的体内生理功能作用。我们将采用最先进的方法,包括各种信号转导分子的显性负突变体,MAPKs,聚焦于TAK1-MKK3信号轴,通过使用短干扰RNA (siRNA)进行基因沉默,以及转基因小鼠,各种TAK1, MKK3, Caveolin-1和自噬基因LC3和Beclin 1的空小鼠。相关性:尽管TGF-ss1在肾纤维化发展中的核心作用已被充分证明,但不加选择地抑制TGF-ss1作用的一般策略可能被证明是不谨慎的。本提案中的研究将为进一步了解TGF-ss1信号转导的分子机制提供重要的新信息,我们可能能够选择性地阻断TGF-ss1有害作用的信号通路。
英文摘要
DESCRIPTION (provided by applicant): Transforming growth factor-beta 1 (TGF-ss1) is a pleiotropic cytokine which controls multiple cellular functions including cell proliferation, differentiation, apoptosis, and extracellular matrix (ECM) synthesis. TGF-ss1 is a potent inducer of ECM protein synthesis and accumulation, and plays a key role in the pathogenesis of progressive diseases as a central mediator of fibrogenesis in a variety of tissues, including the kidney. TGF-ss1 actions are mediated via TGF-ss type I (TssRI) and type II (TssRII) receptors to activate intracellular pathways. Many central questions remain relating to how the distinct receptors mediate TGF-ss1 signals in a cell-specific and context-specific manner to elicit multiple cellular responses. The overall objective of our research is to understand the cellular and molecular mechanisms of renal injury and fibrosis. The major goals are to investigate the mechanisms of TGF-ss1 signaling pathways and their regulation and functional role in injury responses in the kidney. Our hypothesis is that autophagy represents an adaptive stress response to protect against renal injury by inhibiting apoptosis and promoting renal cell survival, and that TGF-ss1 exerts cytoprotective effects via regulating autophagy. Furthermore, we hypothesize that TGF-ss1 signaling via TAK1- MKK3-p38 is the critical mediator of tissue injury response in which TGF-ss1 regulates autophagy proteins which in turn prevents apoptosis and excessive ECM accumulation. This proposal will focus on examining the mechanism and functional role of TGF-ss1 signaling via TAK1 in renal cells, and the regulation of autophagy and its physiological functional role in an experimental model of renal fibrosis. The Specific Aims are: Specific Aim 1: To determine the mechanism and functional role of TGF-ss1 signaling via TAK1 in renal cells Specific Aim 2: To determine the regulation and function of autophagy induced by TGF-ss1 in renal cells. Specific Aim 3: To determine the in vivo physiological functional role of autophagy in an experimental model of renal fibrosis. We will employ state-of-the art approaches including a variety of dominant negative mutants of the signal transducing molecules, the MAPKs, focusing on the TAK1-MKK3 signaling axis, gene silencing by the use short interfering RNA (siRNA), and genetically altered mice, the null mice for the various TAK1, MKK3, Caveolin-1, and the autophagy genes, LC3 and Beclin 1. Relevance: Although the central role of TGF-ss1 in the development of renal fibrosis is well documented, general strategies to indiscriminately inhibit TGF-ss1 actions altogether may prove to be imprudent. The studies in this proposal will yield important and novel information in furthering our understanding of the molecular mechanisms of TGF-ss1 signal transduction, that we may be able to selectively block the pathway that signals the deleterious effects of TGF-ss1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel role of RIPK3-dependent necroptosis pathway in lung and kidney fibrosis
ROLE OF NOVEL SOLUBLE TGF-BETA RECEPTOR IN THE KIDNEY
TGF-beta signaling in the kidney
  • 批准号:
    7617636
  • 项目类别:
  • 资助金额:
    $33.85万
  • 财政年份:
    2000
  • 负责人:
    MARY E CHOI
  • 依托单位:
TGF-beta signaling in the kidney
  • 批准号:
    8466956
  • 项目类别:
  • 资助金额:
    $17.84万
  • 财政年份:
    2000
  • 负责人:
    MARY E CHOI
  • 依托单位:
国内基金
海外基金
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    孙贤杰
  • 依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
  • 批准号:
    82303919
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    陈鹭跃
  • 依托单位: